Ctrl K

PFIZER INC

PFE

Pharmaceutical Preparations

Last filing · Quarter 2 · Jun 28, 2026

Financial Statements Ratios

Export XLSX

Statement

Income Statement Balance Sheet

Period

Annual Quarterly

Order

Unlock 39 quarters

Format

% Change

Rows

USD ($) $ in Millions	Jun 28, 2026	Mar 29, 2026	Sep 28, 2025	Jun 29, 2025	Mar 30, 2025	Sep 29, 2024	Jun 30, 2024	Mar 31, 2024	Oct 1, 2023	Jul 2, 2023	Apr 2, 2023	Oct 2, 2022
Assets
Cash and cash equivalents	$ 976	$ 1,703	$ 1,343	$ 1,638	$ 1,430	$ 1,092	$ 1,052	$ 719	$ 3,148	$ 2,632	$ 2,166	$ 1,298
Short-term investments	10,723	11,372	13,641	11,611	15,887	8,860	6,048	11,209	41,033	42,153	17,806	34,825
Restricted short-term investments	-	-	-	-	-	-	-	-	-	-	-	-
Trade accounts receivable, net of allowance for doubtful accounts: 2026—$423; 2025—$427	12,490	12,585	14,260	12,078	11,845	14,451	11,393	10,989	11,086	10,231	12,305	16,076
Short-term loans	-	-	-	-	-	-	-	-	-	-	-	-
Inventories	9,945	10,667	11,468	11,669	10,852	11,721	11,447	10,892	10,204	10,310	9,541	9,513
Current tax assets	3,702	3,588	3,855	4,016	2,900	3,243	3,694	4,233	3,917	3,194	3,140	2,544
Other current assets	3,522	2,908	2,358	2,690	2,947	3,855	4,190	4,372	4,624	4,828	5,120	6,149
Assets held for sale	-	-	-	-	-	-	-	-	-	-	-	-
Taxes and other current assets	-	-	-	-	-	-	-	-	-	-	-	-
Assets of discontinued operations and other assets held for sale	-	-	-	-	-	-	-	-	-	-	-	-
Total current assets	41,358	42,822	46,924	43,703	45,861	43,223	37,825	42,415	74,012	73,347	50,078	70,403
Equity-method investments	-	-	-	224	224	8,582	8,029	8,123	11,025	11,422	11,175	9,826
Long-term investments	1,559	1,626	2,137	1,896	1,789	2,180	3,119	3,490	3,214	3,644	3,568	4,062
Long-term investments and loans	-	-	-	-	-	-	-	-	-	-	-	-
Property, plant and equipment, net of accumulated depreciation: 2026—$18,104; 2025—$17,386	19,029	19,402	18,880	18,776	18,347	18,541	18,957	18,803	17,862	17,488	17,052	15,441
Identifiable intangible assets, net	47,053	52,559	51,324	52,702	53,976	59,986	61,240	62,829	40,224	41,406	42,002	28,151
Goodwill	71,419	71,409	69,101	68,997	68,444	68,570	68,445	69,297	51,527	51,572	51,476	49,441
Noncurrent deferred tax assets and other noncurrent tax assets	10,774	9,965	11,048	10,343	9,542	7,909	7,867	4,942	8,350	8,261	7,302	7,136
Other noncurrent assets	9,939	9,834	9,317	9,455	9,845	10,486	10,710	11,197	8,808	13,028	12,965	10,890
Taxes and other noncurrent assets	-	-	-	-	-	-	-	-	-	-	-	-
Total assets	201,131	207,618	208,731	206,095	208,028	219,476	216,193	221,095	215,021	220,168	195,617	195,350
Liabilities and Equity
Short-term borrowings, including current portion of long-term debt: 2026—$2,605; 2025—$2,997	2,699	3,890	4,303	4,295	4,470	9,699	11,944	8,232	2,548	3,985	4,188	4,040
Trade accounts payable	4,581	4,506	5,024	5,166	5,240	5,314	5,106	5,591	5,338	6,081	6,123	6,267
Dividends payable	2,451	0	0	2,445	0	0	2,380	0	0	2,315	0	2,245
Income taxes payable	653	3,130	3,799	3,675	3,105	2,877	2,884	3,192	1,898	2,928	1,969	3,071
Accrued compensation and related items	2,554	2,715	3,036	2,447	2,607	3,383	2,566	2,192	2,372	1,972	2,277	2,852
Deferred revenues	-	-	924	1,123	1,012	2,020	2,528	2,502	2,204	1,286	1,750	6,191
Deferred taxes	-	-	-	-	-	-	-	-	-	-	-	-
Other current liabilities	19,709	20,108	19,509	18,575	20,016	19,917	16,410	18,788	16,776	16,079	20,255	19,647
Liabilities held for sale	-	-	-	-	-	-	-	-	-	-	-	-
Total current liabilities	32,646	34,348	36,596	37,726	36,452	43,211	43,819	40,497	31,136	34,647	36,562	44,314
Long-term debt	60,495	60,565	57,409	57,502	57,639	58,002	57,506	61,307	61,048	61,356	31,704	32,629
Pension and postretirement benefit obligations	1,937	1,984	2,157	2,130	2,021	2,073	2,040	2,076	2,166	2,184	2,179	-
Pension benefit obligations	-	-	-	-	-	-	-	-	-	-	-	2,738
Postretirement benefit obligations	-	-	-	-	-	-	-	-	-	-	-	222
Noncurrent deferred tax liabilities	1,964	2,412	2,467	2,481	2,258	2,158	2,227	931	1,125	1,232	1,067	616
Other taxes payable	3,816	3,705	3,401	3,313	5,724	5,905	6,532	8,603	8,099	8,052	9,860	9,701
Other noncurrent liabilities	14,780	14,200	13,605	13,931	13,297	15,569	16,095	15,122	14,242	13,403	13,009	12,239
Total liabilities	115,639	117,214	115,635	117,083	117,391	126,918	128,218	128,537	117,817	120,875	94,381	102,459
Preferred stock	-	-	-	-	-	-	-	-	-	-	-	-
Common stock	482	482	481	481	481	480	480	480	478	478	478	476
Additional paid-in capital	95,033	94,773	94,248	94,053	93,856	93,477	93,197	92,997	92,496	92,329	92,153	91,359
Treasury stock	115,194	115,190	115,011	115,010	115,008	114,760	114,757	114,755	114,485	114,482	114,473	113,945
Employee benefit trusts	-	-	-	-	-	-	-	-	-	-	-	-
Retained earnings	112,087	117,238	121,150	117,609	119,590	121,059	116,596	121,318	126,411	128,796	131,102	122,967
Accumulated other comprehensive loss	(7,218)	(7,203)	(8,066)	(8,438)	(8,581)	(7,971)	(7,816)	(7,758)	(7,966)	(8,102)	(8,289)	(8,225)
Total Pfizer Inc. shareholders’ equity	85,190	90,101	92,801	88,695	90,338	92,286	87,700	92,282	96,934	99,019	100,970	92,631
Equity attributable to noncontrolling interests	302	303	295	317	299	272	275	276	270	274	266	259
Total equity	85,492	90,404	93,096	89,012	90,637	92,558	87,975	92,558	97,204	99,293	101,236	92,891
Total liabilities and equity	$ 201,131	$ 207,618	$ 208,731	$ 206,095	$ 208,028	$ 219,476	$ 216,193	$ 221,095	$ 215,021	$ 220,168	$ 195,617	$ 195,350